Application 219755
- Type
- ANDA
- Sponsor
- INVENTIA HEALTHCARE LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE | 10MG | No | No |
| 003 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE | 5MG | No | No |
| 004 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE | 500MG | No | No |
| 005 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE | 2.5MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dapagliflozin and Metformin Hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Golden State Medical Supply, Inc. | 54027b70-53e7-3710-e063-6394a90aa04c | 2026-06-11 | Boxed warning, Warnings, Adverse reactions | Dapagliflozin and Metformin Hydrochloride |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | e6957674-86c1-4536-8e23-54ad7f2cacc4 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Novadoz Pharmaceuticals LLC | 4f890458-be94-4baf-b606-83a097e1e23e | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
| Dapagliflozin and Metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 513bdf9f-774c-4f7f-935a-54d3885e80a4 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | Dapagliflozin and Metformin hydrochloride |
| Dapagliflozin and Metformin Hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 7d575ca8-9c1f-469d-a341-34daf2f036dd | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | Dapagliflozin and Metformin Hydrochloride |
| Dapagliflozin and Metformin Hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | bddc2d47-8d3d-4c2f-8e5c-7a1a0782219a | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | Dapagliflozin and Metformin Hydrochloride |
| dapagliflozin and metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Ascend Laboratories, LLC | eadcc3ef-f5c2-4a56-a6aa-12909844144e | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | dapagliflozin and metformin hydrochloride |
| dapagliflozin and metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Prasco Laboratories | eaf135b6-e378-4f62-a1e7-db45e23668c7 | 2024-12-20 | Boxed warning, Warnings, Adverse reactions | dapagliflozin and metformin hydrochloride |